Beyond Acyclovir: Tracking the Multi-Billion Dollar Race for Novel...

added blog Health

2025-11-18 11:06:04 -

Beyond Acyclovir: Tracking the Multi-Billion Dollar Race for Novel Antivirals and Therapeutic Vaccines in the Herpes Simplex Virus Treatment Market.

The global health burden of the Herpes Simplex Virus (HSV), encompassing both HSV-1 (often oral) and HSV-2 (primarily genital), is immense. Despite decades of research, the current standard of care largely relies on nucleoside analog antivirals such as acyclovir, valacyclovir, and famciclovir. While highly effective at managing acute outbreaks and suppressing viral replication to reduce...

0 Comments 0 Shares 1K Views 0 Reviews